• Contact
  • IFU
  • MRI
Glaukos Logo
  • Cornea
    • Overview
    • Detecting KC
      • iDetectives
    • Cornea Resources
    • Cornea Reimbursement
    • Cornea Patient Website
  • Cornea
    • Overview
    • Solutions
      • Cross Linking
      • Lasik Xtra
      • KXL System
      • Riboflavin Family
    • Clinical Data
    • Resources
  • Glaucoma
    • Interventional Glaucoma
      • Interventional Glaucoma Practice Media Assets
    • Products
      • iDose® TR
      • iStent infinite®
      • iStent inject® W with Infinite Injector Technology
      • iStent inject® W
      • Other Products
        • iAccess®
        • Mitosol®
    • Clinical Data
      • iDose®TR Clinical Data
      • iStent infinite® Clinical Data
      • iStent inject® W Clinical Data
    • Resources
    • Reimbursement
    • Patient Site
  • Retina
  • About Us
    • Overview
    • Innovation
    • Executive Management
    • Board of Directors
    • Our History
    • Global Charity
    • Awards & Recognition
    • Promotional
  • Investors
  • Careers
    • Overview
    • Life at Glaukos
  • Contact
  • IFU
  • MRI
    • Cornea
    • Overview
      • Detecting KC
      • iDetectives
    • Cornea Resources
    • Cornea Reimbursement
    • Cornea Patient Website
    • Cornea
    • Overview
      • Solutions
      • Cross Linking
      • Lasik Xtra
      • KXL System
      • Riboflavin Family
    • Clinical Data
    • Resources
    • Glaucoma
      • Interventional Glaucoma
      • Interventional Glaucoma Practice Media Assets
      • Products
      • iDose® TR
      • iStent infinite®
      • iStent inject® W with Infinite Injector Technology
      • iStent inject® W
        • Other Products
        • iAccess®
        • Mitosol®
      • Clinical Data
      • iDose®TR Clinical Data
      • iStent infinite® Clinical Data
      • iStent inject® W Clinical Data
    • Resources
    • Reimbursement
    • Patient Site
  • Retina
    • About Us
    • Overview
    • Innovation
    • Executive Management
    • Board of Directors
    • Our History
    • Global Charity
    • Awards & Recognition
    • Promotional
  • Investors
    • Careers
    • Overview
    • Life at Glaukos
iStent infinite® (iS3) iStent inject® W (G2-W)
  • Disease Areas
    • Cornea
    • Interventional Glaucoma
    • Retina
  • Company
    • Innovation
    • Executive Management
    • Board of Directors
    • Our History
    • Global Charity
    • Awards & Recognition
  • Careers
    • Life at Glaukos
    • Talent Acquisition
  • Investors
    • Stock Information
    • Financials & Filings
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Resources & Alerts
  • Policies & Info
    • Terms of Use
    • Privacy Policy
    • Privacy Request Form
    • Declaration of Compliance
    • Talent Acquisition
    • Patents
    • Patient Resources
    • Prescribing Info

©2026 Glaukos Corporation. All rights reserved. Glaukos, Transforming Vision, iDose, iStent, iStent inject, iStent inject W, iStent infinite, and iAccess are registered trademarks of Glaukos Corporation. The KXL system is a registered trademark of Avedro, a Glaukos company. Mitosol is a registered trademark of Mobius Therapeutics, a Glaukos company. PM-US-2978-1

Sign up for:
News & Updates Investor Alerts
Follow Us Online

©2026 Glaukos Corporation. All rights reserved. Glaukos, Transforming Vision, iDose, iStent, iStent inject, iStent inject W, iStent infinite, and iAccess are registered trademarks of Glaukos Corporation. The KXL system is a registered trademark of Avedro, a Glaukos company. Mitosol is a registered trademark of Mobius Therapeutics, a Glaukos company. PM-US-2978-1